Navigation Links
Thoratec Reports 44 Percent Increase in Third Quarter Revenues

onciliation of non-GAAP financial measures contained within this press release with their most directly comparable GAAP financial results and not to rely on any single financial measure to evaluate our business.

The reconciliations of the forward looking non-GAAP financial measures to the most directly comparable GAAP financial measures in the tables below include all information reasonably available to Thoratec at the date of this press release. These tables include adjustments that we can reasonably predict. Events that could cause the reconciliation to change include acquisitions and divestitures of business, goodwill and other asset impairments and sales of marketable equity securities.

The following table includes the GAAP income statement for the three and nine month periods ending 2008 and 2007.


Condensed Consolidated Statements of Operations


(in thousands, except for per share data)

Three Months Ended Nine Months Ended

September 27, September 29, September 27, September 29,

2008 2007 2008 2007

Product sales $80,815 $56,055 $227,890 $170,698

Cost of product sales 32,045 23,707 92,460 70,152

Gross profit 48,770 32,348 135,430 100,546

Operating expenses:

Selling, general and

administrative 23,845 20,873 68,338 61,952

Research and

development 13,443 10,712 38,801 32,372

Amortization of


intangible assets 3,295 3,143 9,887 9,439

Total operating


40,583 34,728 117,026 103,763


SOURCE Thoratec Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related biology technology :

1. Thoratec Schedules Third Quarter 2008 Conference Call, Webcast
2. Thoratec Reports 10 Percent Increase in Fiscal 2007 Revenues; Fourth Quarter Revenues Largest in Company History
3. Thoratec Presentation at JP Morgan Conference to be Webcast
4. Thoratec Announces Appointment of Steven H. Collis to Board of Directors
5. Thoratec Presentation at Bear Stearns Conference To Be Webcast
6. Thoratec Announces HeartMate II(R) PMA Will be Reviewed by FDA Advisory Panel
7. Idenix Pharmaceuticals Reports Third Quarter and Nine Month Financial Results
8. Pharmacyclics Reports First Quarter Fiscal 2009 Financial Results
9. Mylan Reports Adjusted Diluted EPS of $0.23 for the Quarter Ended Sept. 30, 2008
10. Vanda Pharmaceuticals Reports Third Quarter 2008 Results
11. United Therapeutics Reports Third Quarter 2008 Financial Results
Post Your Comments:
(Date:7/25/2014)... July 25, 2014 /PRNewswire-iReach/ -- Xybion Corporation, the ... global corporations operating in highly regulated industries, announced ... annual Global User Group Conference, Xybion International Exchange, ... Philadelphia, Pennsylvania at the Sheraton Society ... This year,s conference theme ...
(Date:7/24/2014)... novel combination of microscopy and data processing has given ... Laboratory an unprecedented look at the surface of a ... , The research team led by ORNL,s Zheng ... perovskite manganite, a complex material that exhibits dramatic magnetic ... behavior could benefit researchers who are interested in using ...
(Date:7/24/2014)...  ECC West Africa, LLC (ECC) signed a contract ... College Hospital (UCH) Ibadan Board of Management for the ... construct, and operate and maintain a new, state-of-the-art Cancer ... the first of the 4-phase project, ECC will conduct ... UCH Ibadan intends to finance and develop the Cancer ...
(Date:7/24/2014)... at the University of Delaware, is known worldwide ... engineering, environmental sustainability and electronics. , His early ... a well-defined, crystalline structure. At the atomic scale, ... zeolites can separate molecules with size differences of ... a nanometer), making them useful to the chemical ...
Breaking Biology Technology:Xybion Announces It Will Host International User Conference in Philadelphia 2Xybion Announces It Will Host International User Conference in Philadelphia 3ORNL study reveals new characteristics of complex oxide surfaces 2ECC Signs a Contract for the Finance, Design, and Construction of a Premier Cancer Institute in Ibadan, Nigeria 2University of Delaware researcher describes new approach for creating organic zeolites 2
... III schizophrenia study, -- In total, nine sales contracts signed since 1 ... ... -- $3 million in revenue already locked in for FY 2009, ... a contract with an international,pharmaceutical company to provide its computerized cognitive testing,technology and associated ...
... YORK, Aug. 11 Bion Environmental,Technologies, Inc. (OTC ... that its U.S. Patent application 11/106,751 entitled "Low ... patent,application was made on April 15, 2005; upon ... and will remain in force until December,26, 2021., ...
... TELK ) reported a net loss of $13.6 million, or ... compared with a net loss of,$14.3 million, or $0.27 per ... loss for the second quarter ended June 30, 2008, includes,a ... reflected in interest and other income (expense)., For the ...
Cached Biology Technology:Sales Contracts Worth $2.3 Million Signed Since 1 July 2008 2Bion Announces Approval of New U.S. Patent for Phosphorus Removal Process for Livestock Waste Environmental Treatment 2Bion Announces Approval of New U.S. Patent for Phosphorus Removal Process for Livestock Waste Environmental Treatment 3Bion Announces Approval of New U.S. Patent for Phosphorus Removal Process for Livestock Waste Environmental Treatment 4Telik Announces Financial Results For 2008 Second Quarter 2Telik Announces Financial Results For 2008 Second Quarter 3Telik Announces Financial Results For 2008 Second Quarter 4
(Date:7/25/2014)... A study published online in the International ... novel approach to preventing cervical cancer based on findings ... after removal of a discrete population of cells in ... study that looked at squamocolumnar junction cells, or SCJ ... have been implicated as the origins of cervical cancer. ...
(Date:7/25/2014)... consume the healthcare community and remain priority ... To address the worldwide crisis of obesity ... global leaders in diabetes, epidemiology and public ... and development of diverse intervention programs in ... This book on "Global Health Perspectives in ...
(Date:7/25/2014)... complex congenital central nervous system disease that is ... tubes during the embryonic phase. Many patients have ... and neurocognitive retardation. Such problems decrease the patients, ... at Ankara Physical Medicine and Rehabilitation Education and ... children with SB, using the Pediatric Evaluation of ...
Breaking Biology News(10 mins):Clearing cells to prevent cervical cancer 2What constitutes an effective response to the global 'diabesity' tsunami? 2
... LAFAYETTE, Ind. - Just months after the soybean genome ... long-sought gene that controls the plant,s main stem growth ... of soybean plants that will allow producers to incorporate ... (Jen-Shin Ma), an assistant professor of agronomy, used the ...
... -- The National Academy of Sciences today announced the ... from 14 countries in recognition of their distinguished and ... held this morning during the business session of the ... today bring the total number of active members to ...
... , April 27 The "Great Reflation Experiment" ... the economy following the recent recession -- has been successful ... says Max Bublitz , chief strategist and portfolio manager ... of Virtus Investment Partners (Nasdaq: VRTS ), ...
Cached Biology News:Gene discovery may lead to new varieties of soybean plants 272 new members chosen by Academy 272 new members chosen by Academy 372 new members chosen by Academy 472 new members chosen by Academy 572 new members chosen by Academy 672 new members chosen by Academy 772 new members chosen by Academy 8Economic Headwinds a 'Very Big Deal' to Virtus Strategist 2Economic Headwinds a 'Very Big Deal' to Virtus Strategist 3Economic Headwinds a 'Very Big Deal' to Virtus Strategist 4
Request Info...
1+ mg expected yield of purified protein, expressed in insect cells - excludes cDNA...
... bioinformatics software that has changed the way ... design of BioNumerics allows for integration and ... data employed for the characterization of organisms ... protein gels, HPLC, VNTR, MLST, SNP, fatty ...
Request Info...
Biology Products: